Unbound MEDLINE

A comparison between meptazinol and dextropropoxyphene plus paracetamol in elderly patients with musculoskeletal pains. Current medical research and opinion. [Curr Med Res Opin] Journal article

 
TitleA comparison between meptazinol and dextropropoxyphene plus paracetamol in elderly patients with musculoskeletal pains.
Author(s)Orö L 
SourceCurr Med Res Opin 1984; 9(4):240-5.
MeSHAcetaminophen
Aged
Azepines
Bone Diseases
Clinical Trials
Comparative Study
Drug Combinations
Female
Humans
Male
Meptazinol
Middle Aged
Muscular Diseases
Pain
Propoxyphene
AbstractThe efficacy and acceptability of meptazinol and dextropropoxyphene plus paracetamol were compared in 32 elderly patients with various types of musculoskeletal pain. A double-blind crossover technique was used. After at least 1 week in hospital, the previous analgesic treatment was stopped and single-blind placebo was given for 1 day. Patients then received, at random, 5-days' treatment with either 200 mg meptazinol 4-times daily or 65 mg dextropropoxyphene plus 650 mg paracetamol 4-times daily before being crossed over to the alternative medication for a further 5 days. If necessary, up to 4 tablets a day were allowed of 500 mg aspirin plus 50 mg caffeine as a 'rescue' analgesic. Assessments were made before (on placebo) and at the end of each treatment period of pain severity and effect on patients' sleep, and details recorded of 'rescue' analgesic consumption and any side-effects. At the end of the trial, an overall assessment was made of the effectiveness and tolerance of each treatment and patients were asked which they preferred. The results showed that both treatments reduced pain severity significantly for all the parameters measured; however, most patients needed additional pain relief. Few side-effects were reported during either treatment period.
Languageeng
Pub Type(s)Clinical Trial
Journal Article
Randomized Controlled Trial
PubMed ID6391829
  
Advertise on this site.